Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in! Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Emerging Approaches in Schizophrenia
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • View All
Back to top Open menu arrow
Download Free PDF

Save Save

Share Share

Cite Cite

Reprints
Sections
No sections available
Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders

Access icon
Schizophrenia/Schizoaffective Disorders

Brief Report December 15, 2005

Brief Report: Aripiprazole for the Treatment of Tourette's Disorder

Prasad R. Padala ; S. Faiz Qadri ; Vishal Madaan

Prim Care Companion J Clin Psychiatry 2005;7(6):296-299

Article Abstract
Brief Report: Aripiprazole for the Treatment of Tourette’s Disorder

Download Free PDF

This PDF is free for all visitors!

Save Save

Share Share

Cite Cite

Related News Articles

Weekly Mind Reader: Delusion vs. Reality Weekly Mind Reader: A Question of Ethics Genetics, Income, and Opportunity Shape Socio-Economic Outcomes

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia
Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Related JCP Articles

Clozapine Monitoring in the Post-REMS World: Some Guidance for Clinicians Xanomeline and Trospium Chloride for Agitation Associated With Schizophrenia Pharmacokinetics of Olanzapine Intranasal Spray vs Olanzapine IM

Related PCC Articles

Substance Use in Pregnant and Postpartum Women Low-Dose Clozapine in Schizophrenia With Aggression Recurrent Catatonia Following Hypothyroidism

Vol 27 • 2025 • Number 2

Read the Current Issue

Original Research

What Internists and Neurologists Know and Think About Catatonia

Original Research

Psychological Morbidities in Hospital Staff During Nipah Virus

Systematic Review

Exercise and Fibromyalgia Pain

Rounds in the General Hospital

Managing Anxiety, Agitation, and Pain in Critically Ill Patients

Review Article

Quality Indicators in Community Mental Health Services: A Scoping Review

Case Report

Is My Patient Diverting Their Lorazepam?

View current Issue

Related Articles

PCC
Treatment Decision-Making Capacity With the MacCAT-T in Schizophrenia
Brief Report

Treatment Decision-Making Capacity With the MacCAT-T in Schizophrenia

June 1, 2023

This report is a narrative review of the studies on schizophrenia that evaluated both decision-making capacity for treatment with the MacCAT-T and severity of symptoms using a clinical rating...
Hirofumi Hirakawa
PCC
Brief Report

Omission of Amisulpride From the US Residency Training Curriculum

November 4, 2021

In this report, the author discusses the second-generation antipsychotic amisulpride, which is used around the world for treatment of schizophrenia but is not approved for any mental health indication...
Mayank Gupta
JCP
Brief Report

Clozapine Is Associated With Higher COVID-19 Infection Rate in Veterans With Schizophrenia

August 24, 2021

Does clozapine treatment increase the odds of testing positive for COVID-19? This small study of a VA patient population posed the question.
Olaoluwa O. Okusaga , Brian G. Mitchell , Jared D. Bernard , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2025 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap